{
  "id": 5437,
  "text": "Am J Clin Oncol 1996;19:439-441.Available at: http://www.ncbi.nlm.nih.gov/pubmed/8823469.256.Schilder RJ, Blessing J, Cohn DE.Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Am J Clin Oncol 1996;19:439-441.Available at: http://www.ncbi.nlm.nih.gov/pubmed/8823469.256.Schilder RJ, Blessing J, Cohn DE.Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据研究，吉西他滨在先前接受过治疗的宫颈非鳞状细胞癌患者中的应用已在妇科肿瘤组的一项II期研究中进行了评估。这项研究对其在此类患者群体中的疗效进行了深入探讨，为临床提供了相关数据支持。",
  "query": "以前接受过治疗的宫颈非鳞状细胞癌患者在使用吉西他滨方面是否进行了研究评估？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 以前接受过治疗的宫颈非鳞状细胞癌患者在使用吉西他滨方面是否进行了研究评估？\n\n<reference text>: Am J Clin Oncol 1996;19:439-441.Available at: http://www.ncbi.nlm.nih.gov/pubmed/8823469.256.Schilder RJ, Blessing J, Cohn DE.Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据研究，吉西他滨在先前接受过治疗的宫颈非鳞状细胞癌患者中的应用已在妇科肿瘤组的一项II期研究中进行了评估。这项研究对其在此类患者群体中的疗效进行了深入探讨，为临床提供了相关数据支持。"
}